IDENTIV INC (INVE)

US45170X2053 - Common Stock

3.77  +0.11 (+3.01%)

Fundamental Rating

3

Taking everything into account, INVE scores 3 out of 10 in our fundamental rating. INVE was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of INVE is average, but there are quite some concerns on its profitability. INVE is valued expensive and it does not seem to be growing.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

INVE had negative earnings in the past year.
In the past year INVE has reported a negative cash flow from operations.
INVE had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: INVE reported negative operating cash flow in multiple years.

1.2 Ratios

INVE's Return On Assets of 40.99% is amongst the best of the industry. INVE outperforms 100.00% of its industry peers.
The Return On Equity of INVE (46.30%) is better than 98.35% of its industry peers.
Industry RankSector Rank
ROA 40.99%
ROE 46.3%
ROIC N/A
ROA(3y)-2.4%
ROA(5y)-3.61%
ROE(3y)-3.52%
ROE(5y)-6.97%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of INVE (148.36%) is better than 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 23.51%, INVE is doing worse than 61.98% of the companies in the same industry.
In the last couple of years the Gross Margin of INVE has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 148.36%
GM 23.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.24%
GM growth 5Y-3.21%

More info and screens

6

2. Health

2.1 Basic Checks

INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INVE has more shares outstanding
The number of shares outstanding for INVE has been increased compared to 5 years ago.
Compared to 1 year ago, INVE has a worse debt to assets ratio.

2.2 Solvency

INVE has an Altman-Z score of 0.83. This is a bad value and indicates that INVE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.83, INVE is doing worse than 76.03% of the companies in the same industry.
INVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACCN/A
WACC10.38%

2.3 Liquidity

INVE has a Current Ratio of 8.73. This indicates that INVE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.73, INVE belongs to the best of the industry, outperforming 91.74% of the companies in the same industry.
A Quick Ratio of 8.17 indicates that INVE has no problem at all paying its short term obligations.
INVE's Quick ratio of 8.17 is amongst the best of the industry. INVE outperforms 92.56% of its industry peers.
Industry RankSector Rank
Current Ratio 8.73
Quick Ratio 8.17

More info and screens

2

3. Growth

3.1 Past

The earnings per share for INVE have decreased strongly by -380.00% in the last year.
INVE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.98%.
INVE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.30% yearly.
EPS 1Y (TTM)-380%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3900%
Revenue 1Y (TTM)-57.98%
Revenue growth 3Y10.23%
Revenue growth 5Y8.3%
Sales Q2Q%-79.49%

3.2 Future

The Earnings Per Share is expected to decrease by -51.79% on average over the next years. This is quite bad
The Revenue is expected to grow by 3.57% on average over the next years.
EPS Next Y-322.57%
EPS Next 2Y-88.94%
EPS Next 3Y-51.79%
EPS Next 5YN/A
Revenue Next Year-59.37%
Revenue Next 2Y-55.55%
Revenue Next 3Y-34.79%
Revenue Next 5Y3.57%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INVE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

INVE's earnings are expected to decrease with -51.79% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-88.94%
EPS Next 3Y-51.79%

More info and screens

0

5. Dividend

5.1 Amount

INVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IDENTIV INC

NASDAQ:INVE (1/3/2025, 8:00:02 PM)

3.77

+0.11 (+3.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners58.1%
Inst Owner Change-9.75%
Ins Owners6.62%
Ins Owner Change2.34%
Market Cap90.07M
Analysts82.22
Price Target7.31 (93.9%)
Short Float %0.58%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.39%
Min EPS beat(2)-58.98%
Max EPS beat(2)-41.8%
EPS beat(4)0
Avg EPS beat(4)-67.59%
Min EPS beat(4)-135.32%
Max EPS beat(4)-34.27%
EPS beat(8)2
Avg EPS beat(8)-52.18%
EPS beat(12)4
Avg EPS beat(12)-73.44%
EPS beat(16)7
Avg EPS beat(16)-48.49%
Revenue beat(2)1
Avg Revenue beat(2)3.51%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)7.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)7.63%
Revenue beat(8)1
Avg Revenue beat(8)-2.58%
Revenue beat(12)2
Avg Revenue beat(12)-3.37%
Revenue beat(16)3
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)-6.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-91.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-71.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.84
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-1
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS2.05
BVpS6.56
TBVpS6.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 40.99%
ROE 46.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 148.36%
GM 23.51%
FCFM N/A
ROA(3y)-2.4%
ROA(5y)-3.61%
ROE(3y)-3.52%
ROE(5y)-6.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.24%
GM growth 5Y-3.21%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.36%
Cap/Sales 4.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.73
Quick Ratio 8.17
Altman-Z 0.83
F-Score4
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)144.9%
Cap/Depr(5y)97.99%
Cap/Sales(3y)3.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-380%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3900%
EPS Next Y-322.57%
EPS Next 2Y-88.94%
EPS Next 3Y-51.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-57.98%
Revenue growth 3Y10.23%
Revenue growth 5Y8.3%
Sales Q2Q%-79.49%
Revenue Next Year-59.37%
Revenue Next 2Y-55.55%
Revenue Next 3Y-34.79%
Revenue Next 5Y3.57%
EBIT growth 1Y-777.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-237.08%
EBIT Next 3Y89.78%
EBIT Next 5Y49.28%
FCF growth 1Y-36.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-164.97%
OCF growth 3YN/A
OCF growth 5YN/A